Qube Research & Technologies LTD Icad Inc Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.8 - $3.61 $3 - $7	2 New	2 $0
Q3 2022 Nov 14, 2022	SELL	$2.04 - $4.32 $1,701 - $3,602	-834 Reduced 4.45%	17,895 $38,000
Q2 2022 Aug 15, 2022	BUY	$3.02 - $4.56 $56,561 - $85,404	18,729 New	18,729 $75,000
Q2 2020 Aug 14, 2020	SELL	$6.63 - $12.85 $182,895 - $354,480	-27,586 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.94 - $14.42 $375,856 - $780,958	-54,158 Reduced 66.25%	27,586 $202,000
Q4 2019 Feb 13, 2020	BUY	$6.23 - $7.98 $509,265 - $652,317	81,744 New	81,744 $635,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $42.6M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.